Hims & Hers Health (HIMS) Return on Capital Employed (2020 - 2026)
Hims & Hers Health (HIMS) posted Return on Capital Employed of 1.92% for Q1 2026, down 132.57% sequentially from 5.9% in Q4 2025, and down 2309.0% YoY from 0.09% in Q1 2025.
Hims & Hers Health (HIMS) Return on Capital Employed (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Return on Capital Employed for 7 years, with the latest figure at 1.92% in Q1 2026.
- Quarterly Return on Capital Employed fell 2309.0% year-over-year to 1.92% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.92% (down 2309.0% YoY) and the FY2025 annual result came in at 10.29%, down 725.0% from the prior year.
- Return on Capital Employed fell to 1.92% in Q1 2026 per HIMS's latest filing, from 5.9% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 21.16% in Q1 2025 and troughed at 26.53% in Q2 2022.
- A 5-year average of 4.95% and a median of 2.36% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2026: Return on Capital Employed jumped 2377 bps in 2024, then sank 2309 bps in 2026.
- Over 5 years, Return on Capital Employed stood at 21.03% in 2022, then jumped by 59 bps to 8.69% in 2023, then jumped by 264 bps to 14.28% in 2024, then tumbled by 59 bps to 5.9% in 2025, then plunged by 133 bps to 1.92% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 1.92%, 5.9%, and 7.17% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Hims & Hers Health | 7.49 Bn | 6.65 Bn | 480.80 Mn | -10.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.55% |
| Mar 31, 2026 | -1.92% |
| Dec 31, 2025 | 5.90% |
| Sep 30, 2025 | 7.17% |
| Jun 30, 2025 | 11.29% |
| Mar 31, 2025 | 21.16% |
| Dec 31, 2024 | 14.28% |
| Sep 30, 2024 | 11.04% |
| Jun 30, 2024 | 3.37% |
| Mar 31, 2024 | -2.36% |
| Dec 31, 2023 | -8.69% |
| Sep 30, 2023 | -12.73% |
| Jun 30, 2023 | -16.45% |
| Mar 31, 2023 | -20.01% |
| Dec 31, 2022 | -21.03% |
| Sep 30, 2022 | -25.00% |
| Jun 30, 2022 | -26.53% |
| Mar 31, 2022 | -23.68% |
| Dec 31, 2021 | -33.73% |
| Sep 30, 2021 | -29.60% |